Abacioglu U Interview with Dr Michael Weller (Zurich) about the Phase-III EGFRvIII Vaccine Trial on Newly Diagnosed EGFRvIII-Positive Glioblastoma European Association of NeuroOncology Magazine 2013; 3 (3): 155-156 PDF Overview | ||
Figure/Graphic 1: ACT IV Trial scheme |
Figure/Graphic 1: ACT IV
Trial scheme |
